Werewolf Therapeutics, Inc.
HOWL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785530
In the last 90 days, Werewolf Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 45 institutions reported holding it in 13F filings for Q2 2026, worth $3.91M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Werewolf Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −2 vs. Q1 2023
- Shares held
- 24.0M
- +54.5K (+0.2%) vs. Q1 2023
- Total value
- $73.3M
- +$10.8M (+17.4%) vs. Q1 2023
- New holders
- 2
- 10 more added
- Sold out
- 4
- 3 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HOWL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $3.91M |
| Q1 2026 | 48 | $11.7M |
| Q4 2025 | 51 | $9.34M |
| Q3 2025 | 62 | $41.6M |
| Q2 2025 | 65 | $24.3M |
| Q1 2025 | 70 | $26.7M |
| Q4 2024 | 73 | $41.7M |
| Q3 2024 | 69 | $68.3M |
| Q2 2024 | 71 | $79.2M |
| Q1 2024 | 61 | $209.0M |
| Q4 2023 | 41 | $106.8M |
| Q3 2023 | 35 | $51.1M |
| Q2 2023 | 36 | $73.3M |
| Q1 2023 | 38 | $62.5M |
| Q4 2022 | 39 | $42.8M |
| Q3 2022 | 44 | $94.5M |
| Q2 2022 | 46 | $78.0M |
| Q1 2022 | 49 | $83.5M |
| Q4 2021 | 51 | $228.3M |
| Q3 2021 | 42 | $326.2M |
| Q2 2021 | 45 | $344.3M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Werewolf Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Glassman Wealth Services | 5 | $15 | 0.00% | 00.0% | Unchanged |
| GHP Investment Advisors, Inc. | 80 | $209 | 0.00% | +80 | New |
| Wells Fargo & Company | 136 | $415 | 0.00% | +40+41.7% | Added |
| Simplex Trading, LLC | 629 | $1.00K | 0.00% | +629 | New |
| JPMorgan Chase & Co | 748 | $2.28K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,000 | $3.05K | 0.00% | 00.0% | Unchanged |
| Financial Perspectives, Inc | 1,250 | $3.81K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 2,100 | $6.41K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2,500 | $7.63K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,827 | $8.62K | 0.00% | +1,303+85.5% | Added |
| Two Sigma Investments, LP | 16,537 | $50.4K | 0.00% | −9,300−36.0% | Reduced |
| Prudential Financial Inc | 19,800 | $60.4K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 24,613 | $75.1K | 0.00% | +11,287+84.7% | Added |
| Northern Trust Corp | 26,067 | $79.5K | 0.00% | +6,161+31.0% | Added |
| HBK Sorce Advisory LLC | 26,454 | $80.7K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 42,900 | $131.0K | 0.00% | +8,800+25.8% | Added |
| Edgewood Management LLC | 50,000 | $152.5K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 50,768 | $154.8K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 73,981 | $225.6K | 0.00% | +34,987+89.7% | Added |
| Acadian Asset Management LLC | 78,671 | $238.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 85,511 | $260.8K | 0.01% | +3,800+4.7% | Added |
| Geode Capital Management, LLC | 165,315 | $504.2K | 0.00% | +35,483+27.3% | Added |
| Schonfeld Strategic Advisors LLC | 326,702 | $996.4K | 0.01% | +253,284+345.0% | Added |
| Alyeska Investment Group, L.P. | 397,808 | $1.21M | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 463,914 | $1.41M | 0.00% | 00.0% | Unchanged |
| Laurion Capital Management LP | 522,900 | $1.59M | 0.07% | 00.0% | Unchanged |
| DC Funds, LP | 589,102 | $1.80M | 38.27% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 626,810 | $1.91M | 0.41% | 00.0% | Unchanged |
| Millennium Management LLC | 859,247 | $2.62M | 0.00% | −238,101−21.7% | Reduced |
| Adage Capital Partners GP, L.L.C. | 1,000,597 | $3.05M | 0.01% | 00.0% | Unchanged |
| Bank of America Corp | 1,529,855 | $4.67M | 0.00% | −1,608−0.1% | Reduced |
| Rubric Capital Management LP | 1,935,357 | $5.90M | 0.25% | 00.0% | Unchanged |
| PFM Health Sciences, LP | 2,303,891 | $7.03M | 0.28% | +86,671+3.9% | Added |
| MPM Oncology Impact Management LP | 2,388,011 | $7.28M | 1.47% | 00.0% | Unchanged |
| MPM Asset Management LLC | 4,284,172 | $13.1M | 6.41% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 6,144,881 | $18.7M | 0.35% | 00.0% | Unchanged |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −120,936−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | – | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −18,127−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −2−100.0% | Sold out |